Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | DGAT2 | Q96PD7 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1263992 | 0.91 | NPC1 (0.36) | RXFP1NPC1RAB9APOLBALDH1A1 | |
| SCHEMBL1263955 | 0.90 | NPC1 (0.40) | RXFP1NPC1RAB9APOLBALDH1A1 | |
| SCHEMBL1939059 | 0.88 | RAB9A (0.38) | RXFP1NPC1RAB9APOLBALDH1A1 | |
| SCHEMBL1263216 | 0.86 | NPC1 (0.40) | NPC1RAB9APOLBALDH1A1SMN1; SMN2 | |
| SCHEMBL1263990 | 0.83 | NPC1 (0.42) | NPC1RAB9APOLBALDH1A1SMN1; SMN2 | |
| SCHEMBL1263994 | 0.75 | NPC1 (0.52) | NPC1RAB9APOLBALDH1A1SMN1; SMN2 | |
| SCHEMBL1264046 | 0.75 | NPC1 (0.42) | NPC1RAB9APOLBALDH1A1SMN1; SMN2 | |
| SCHEMBL1263210 | 0.75 | NPC1 (0.42) | NPC1RAB9APOLBALDH1A1SMN1; SMN2 | |
| SCHEMBL1263991 | 0.73 | NPC1 (0.40) | NPC1RAB9APOLBALDH1A1SMN1; SMN2 | |
| SCHEMBL1264001 | 0.71 | NPC1 (0.45) | NPC1RAB9APOLBALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110038816-A1 | Ultraviolet light absorbing ketones of 2-(2-hydroxyhenyl) benzotriazole | CHANG CHIA-HU | 2011-02-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110038816-A1 | Ultraviolet light absorbing ketones of 2-(2-hydroxyhenyl) benzotriazole | HCRTR2, HCRTR1, POLL | RXFP1 4389/4885NPC1 2019/4885RAB9A 4833/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.